SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001609351-18-000076
Filing Date
2018-11-06
Accepted
2018-11-06 16:37:30
Documents
72
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q spark-201893010xq.htm 10-Q 1174487
2 EXHIBIT 10.1 brammeragreementex-101.htm EX-10.1 369764
3 EXHIBIT 10.2 creditagreementex-102.htm EX-10.2 401399
4 EXHIBIT 10.3 cashcollateralagreementex-.htm EX-10.3 38156
5 EXHIBIT 31.1 spark-2018930exx311.htm EX-31.1 21900
6 EXHIBIT 31.2 spark-2018930exx312.htm EX-31.2 21899
7 EXHIBIT 32.1 spark-2018930exx321.htm EX-32.1 6998
8 EXHIBIT 32.2 spark2018930ex-322.htm EX-32.2 6877
  Complete submission text file 0001609351-18-000076.txt   5707849

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT once-20180930.xml EX-101.INS 700556
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT once-20180930.xsd EX-101.SCH 40990
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT once-20180930_cal.xml EX-101.CAL 73265
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT once-20180930_def.xml EX-101.DEF 208720
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT once-20180930_lab.xml EX-101.LAB 570759
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT once-20180930_pre.xml EX-101.PRE 351357
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36819 | Film No.: 181163508
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1